INDIANAPOLIS, IN -- (MARKET WIRE) -- October 27, 2006 -- New data suggest that Strattera® (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced today at a meeting of child and adolescent psychiatrists.
